2005Unpublished venueRequires access

Comparison of mirtazapine versus clomipramine in maintenance treatment of depression

Jia Jin-din

Open publisher page 2 citations

Abstract

Objective:To compare the efficacy of mirtazapine and clomipramine in the maintenance treatment of depression.Method:[WTBZ]Sixty depressive outpatients were randomly allocated to two groups treated with mirtazapine or clomipramine for 54 weeks. All the patients were assessed with Hamilton depression scale (HAMD), clinical global impression(CGI)and the treatment emergent symptom scale (TESS) before and after treatment for 12 weeks and 54 weeks.Results:After 12 weeks treatments,significant improvement was observed in both groups,but no significant difference was found between two groups.After 54 weeks,the efficacy was significantly better in mirtazapine group than in clomipramine group,however the adverse effects was much less in mirtazapine group than in clomipramine group.Conclusion:Mirtazapine has better efficacy and less adverse effects in the maintenance treatment of depression.

About this research paper

What this paper is about

Objective:To compare the efficacy of mirtazapine and clomipramine in the maintenance treatment of depression.Method:[WTBZ]Sixty depressive outpatients were randomly allocated to two groups treated with mirtazapine or clomipramine for 54 weeks. All the patients were assessed with Hamilton depression scale (HAMD), clinical global impression(CGI)and the treatment emergent symptom scale (TESS) before and after treatment for 12 weeks and 54 weeks.Results:After 12 weeks treatments,significant improvement was observed in both groups,but no significant difference was found between two groups.After 54 weeks,the efficacy was significantly better in mirtazapine group than in clomipramine group,however the adverse effects was much less in mirtazapine group than in clomipramine group.Conclusion:Mirtazapine has better efficacy and less adverse effects in the maintenance treatment of depression.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To compare the efficacy of mirtazapine and clomipramine in the maintenance treatment of depression.Method:[WTBZ]Sixty depressive outpatients were randomly allocated to two groups treated with mirtazapine or clomipramine for 54 weeks. All the patients were assessed with Hamilton depression scale (HAMD), clinical global impression(CGI)and the treatment emergent symptom scale (TESS) before and after treatment for 12 weeks and 54 weeks.Results:After 12 weeks treatments,significant improvement was observed in both groups,but no significant difference was found between two groups.After 54 weeks,the efficacy was significantly better in mirtazapine group than in clomipramine group,however the adverse effects was much less in mirtazapine group than in clomipramine group.Conclusion:Mirtazapine has better efficacy and less adverse effects in the maintenance treatment of depression.

Key concepts: Mirtazapine, Clomipramine, Hamd, Clinical Global Impression, Depression (economics), Adverse effect, Psychology, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparison of mirtazapine versus clomipramine in maintenance treatment of depression — Research Paper | ScholarLens